Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL-39324 vs Lucentis in wet AMD
NCT00992563Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Jun 2010
- Primary completion
- May 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of linifanib in age-related macular degeneration (AMD), sponsored by Alcon Inc.. Started Jun 2010; status: completed.
02
Drugs
linifanib
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT00992563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00992563.